Page last updated: 2024-11-01

omeprazole and Ache

omeprazole has been researched along with Ache in 36 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
"To compare the efficacy of curcumin versus omeprazole in improving patient reported outcomes in people with dyspepsia."9.69Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial. ( Angsusing, J; Buamahakul, T; Chumsri, C; Khamsai, S; Khongkha, W; Kongkam, P; Kosarussawadee, P; Lopimpisuth, C; Phisalprapa, P; Phutrakool, P; Pongpirul, K; Poonniam, P; Sawanyawisuth, K; Siwamogsatham, S; Sura, T; Teerachaisakul, M; Wanaratna, K, 2023)
"In controlled clinical trials, rabeprazole effectively improves symptoms and heals oesophageal erosions in patients with gastro-oesophageal reflux disease (GORD)."9.11Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study. ( Archimandritis, AJ; Avgerinos, A; Kouklakis, G; Nikolopoulou, V; Paraskevas, E; Triantafillidis, JK; Tsianos, E, 2005)
"In the intention-to-treat population, a complete relief of overall primary symptoms of dyspepsia was achieved after 2 weeks in 53% of patients receiving lansoprazole and in 41% of patients receiving omeprazole (P = 0."9.09Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia. ( Crouch, SL; Jones, R, 1999)
"The purpose of this multicenter, randomized, double-blind study, conducted in 520 patients, was to compare the efficacy and safety of omeprazole (40 and 20 mg once daily) with placebo in the treatment of benign gastric ulcer."9.08Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study. ( Colón Pagán, JR; Gilde, LR; Kogut, DG; McCullough, AJ; Shah, U; Simon, TJ; Valenzuela, JE; Whipple, J, 1996)
"In this randomized, double-blind, multicentre study, conducted at 25 European sites, rabeprazole and omeprazole were compared in patients with active gastric ulcers."9.08Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group. ( Beker, JA; Bell, NE; Dekkers, CP; Gabryelewicz, A; Humphries, TJ; Thjodleifsson, B, 1998)
"The proton pump inhibitors pantoprazole and omeprazole were compared in a randomized, double-blind study in 219 patients with benign gastric ulcers."9.08Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. ( Gütz, H; Hüttemann, W; Schepp, W; Witzel, L, 1995)
"In a Swedish-Norwegian multicentre study patients with endoscopically verified duodenal ulcers (greater than 5 mm) were randomized to 2 or 4 weeks of treatment with either 20 mg omeprazole once daily or 300 mg ranitidine once daily."9.07Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research. ( Carling, L; Engström, G; Glise, H; Hallerbäck, B; Martinson, J; Solhaug, JH; Unge, P, 1991)
"The efficacy of lansoprazole (30 mg/d) and omeprazole (20 mg/d) has been assessed in active duodenal ulcer disease in 144 patients included in a multicentric, randomized, double-blind trial."9.07[Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial]. ( Andrieu, J; Coste, T; Dupuis, J; Grimaud, JC; Julien, H; Lemerez, M; Licht, H; Petite, JP; Sallerin, V; Slama, JL, 1993)
"To assess the comparative efficacy of omeprazole 20 mg in the morning versus ranitidine 150 mg twice a day, in the healing of duodenal ulcer, 43 endoscopically verified cases were randomly allocated to 2 or 4 weeks (if ulcer did not heal at 2 weeks) treatment."9.07Omeprazole vs ranitidine in the healing of duodenal ulcer. ( Ahmed, W; Alam, SE; Qureshi, H; Zuberi, SJ, 1993)
"Sixty patients with symptomatic duodenal ulcer were randomized to receive either omeprazole (20 mg each morning) or famotidine (40 mg at night time) for 2-4 weeks in a double-blind parallel group clinical trial."9.07Omeprazole versus famotidine in the healing and relapse of duodenal ulcer. ( Dasarathy, S; Misra, SC; Sharma, MP, 1993)
"We conducted a double-blind, randomized, parallel group study in 169 patients with acute duodenal ulcers to compare omeprazole, 20 mg daily, with cimetidine, 600 mg twice daily."9.06Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. ( Archambault, AP; Bailey, RJ; Baker, SJ; Freeman, HJ; Hunt, RH; Marcon, NE; Navert, H; Pare, P; Sutherland, L; Williams, CN, 1988)
"The object of this double-blind, multicentre study was to compare duodenal ulcer healing rates after 2 to 4 weeks of treatment with either 20 mg omeprazole o."9.06Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.d.) in duodenal ulcer healing and pain relief. ( Cluysenaer, OJ; Gerrits, C; Hazenberg, BP; Meyer, WW; Mulder, CJ; Nicolai, JJ; Stuifbergen, WH; Tijtgat, GN; Vogten, AJ, 1989)
"One-hundred and seventy-one patients with endoscopically proven duodenal ulcers were allocated at random to double-blind treatment with 10 or 20 mg of omeprazole in the morning for up to 4 weeks."9.06Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer: double-blind comparative trial. ( Andersen, BN; Eriksen, J; Hansen, J; Havelund, T; Jørgensen, T; Lauritsen, K; Laursen, LS; Rask-Madsen, J, 1989)
"We conducted a double-blind randomized study of 132 patients to determine whether the new, investigational proton-pump inhibitor, omeprazole (30 mg per day), would accelerate healing and pain relief, as compared with cimetidine (1 g per day), in patients with duodenal ulcer."9.05Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. ( Andersen, HH; Bendtsen, F; Bytzer, P; Højlund, M; Jensen, KG; Kelbaek, H; Lauritsen, K; Linde, J; Rask-Madsen, J; Rune, SJ, 1985)
"Our data suggest that the opioid system, particularly beta-endorphin, is involved in the perception of pain in duodenal ulcer disease, which explains the silent clinical characteristics of some peptic ulcers."7.69Beta-endorphin in silent duodenal ulcer. ( Chianelli, M; Delle Fave, G; Mariani, P; Negri, M; Tonnarini, GF, 1995)
"To compare the efficacy of curcumin versus omeprazole in improving patient reported outcomes in people with dyspepsia."5.69Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial. ( Angsusing, J; Buamahakul, T; Chumsri, C; Khamsai, S; Khongkha, W; Kongkam, P; Kosarussawadee, P; Lopimpisuth, C; Phisalprapa, P; Phutrakool, P; Pongpirul, K; Poonniam, P; Sawanyawisuth, K; Siwamogsatham, S; Sura, T; Teerachaisakul, M; Wanaratna, K, 2023)
"In controlled clinical trials, rabeprazole effectively improves symptoms and heals oesophageal erosions in patients with gastro-oesophageal reflux disease (GORD)."5.11Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study. ( Archimandritis, AJ; Avgerinos, A; Kouklakis, G; Nikolopoulou, V; Paraskevas, E; Triantafillidis, JK; Tsianos, E, 2005)
"In the intention-to-treat population, a complete relief of overall primary symptoms of dyspepsia was achieved after 2 weeks in 53% of patients receiving lansoprazole and in 41% of patients receiving omeprazole (P = 0."5.09Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia. ( Crouch, SL; Jones, R, 1999)
" Treating duodenal ulcer with simultaneous administration of omeprazole achieves ulcer pain relief more rapidly."5.09Does eradication of Helicobacter pylori alone heal duodenal ulcers? ( Chen, Y; Ge, ZZ; Hu, YB; Xiao, SD; Zhang, DZ, 2000)
"In this randomized, double-blind, multicentre study, conducted at 25 European sites, rabeprazole and omeprazole were compared in patients with active gastric ulcers."5.08Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group. ( Beker, JA; Bell, NE; Dekkers, CP; Gabryelewicz, A; Humphries, TJ; Thjodleifsson, B, 1998)
"The purpose of this multicenter, randomized, double-blind study, conducted in 520 patients, was to compare the efficacy and safety of omeprazole (40 and 20 mg once daily) with placebo in the treatment of benign gastric ulcer."5.08Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study. ( Colón Pagán, JR; Gilde, LR; Kogut, DG; McCullough, AJ; Shah, U; Simon, TJ; Valenzuela, JE; Whipple, J, 1996)
"The proton pump inhibitors pantoprazole and omeprazole were compared in a randomized, double-blind study in 219 patients with benign gastric ulcers."5.08Pantoprazole versus omeprazole in the treatment of acute gastric ulcers. ( Gütz, H; Hüttemann, W; Schepp, W; Witzel, L, 1995)
"To assess the comparative efficacy of omeprazole 20 mg in the morning versus ranitidine 150 mg twice a day, in the healing of duodenal ulcer, 43 endoscopically verified cases were randomly allocated to 2 or 4 weeks (if ulcer did not heal at 2 weeks) treatment."5.07Omeprazole vs ranitidine in the healing of duodenal ulcer. ( Ahmed, W; Alam, SE; Qureshi, H; Zuberi, SJ, 1993)
"In a Swedish-Norwegian multicentre study patients with endoscopically verified duodenal ulcers (greater than 5 mm) were randomized to 2 or 4 weeks of treatment with either 20 mg omeprazole once daily or 300 mg ranitidine once daily."5.07Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research. ( Carling, L; Engström, G; Glise, H; Hallerbäck, B; Martinson, J; Solhaug, JH; Unge, P, 1991)
"The efficacy of lansoprazole (30 mg/d) and omeprazole (20 mg/d) has been assessed in active duodenal ulcer disease in 144 patients included in a multicentric, randomized, double-blind trial."5.07[Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial]. ( Andrieu, J; Coste, T; Dupuis, J; Grimaud, JC; Julien, H; Lemerez, M; Licht, H; Petite, JP; Sallerin, V; Slama, JL, 1993)
"Sixty patients with symptomatic duodenal ulcer were randomized to receive either omeprazole (20 mg each morning) or famotidine (40 mg at night time) for 2-4 weeks in a double-blind parallel group clinical trial."5.07Omeprazole versus famotidine in the healing and relapse of duodenal ulcer. ( Dasarathy, S; Misra, SC; Sharma, MP, 1993)
"One-hundred and seventy-one patients with endoscopically proven duodenal ulcers were allocated at random to double-blind treatment with 10 or 20 mg of omeprazole in the morning for up to 4 weeks."5.06Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer: double-blind comparative trial. ( Andersen, BN; Eriksen, J; Hansen, J; Havelund, T; Jørgensen, T; Lauritsen, K; Laursen, LS; Rask-Madsen, J, 1989)
"Endoscopic evidence of accelerated healing of type I gastric ulcers after four weeks of omeprazole."5.06Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group. ( , 1989)
"The object of this double-blind, multicentre study was to compare duodenal ulcer healing rates after 2 to 4 weeks of treatment with either 20 mg omeprazole o."5.06Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.d.) in duodenal ulcer healing and pain relief. ( Cluysenaer, OJ; Gerrits, C; Hazenberg, BP; Meyer, WW; Mulder, CJ; Nicolai, JJ; Stuifbergen, WH; Tijtgat, GN; Vogten, AJ, 1989)
"We conducted a double-blind, randomized, parallel group study in 169 patients with acute duodenal ulcers to compare omeprazole, 20 mg daily, with cimetidine, 600 mg twice daily."5.06Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. ( Archambault, AP; Bailey, RJ; Baker, SJ; Freeman, HJ; Hunt, RH; Marcon, NE; Navert, H; Pare, P; Sutherland, L; Williams, CN, 1988)
"We conducted a double-blind randomized study of 132 patients to determine whether the new, investigational proton-pump inhibitor, omeprazole (30 mg per day), would accelerate healing and pain relief, as compared with cimetidine (1 g per day), in patients with duodenal ulcer."5.05Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. ( Andersen, HH; Bendtsen, F; Bytzer, P; Højlund, M; Jensen, KG; Kelbaek, H; Lauritsen, K; Linde, J; Rask-Madsen, J; Rune, SJ, 1985)
" The case presentation illustrates the role of pregabalin in successful medical management of this chronic pain disorder, as well as the management of common psychiatric morbidities associated with this condition."3.74Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia. ( Jerome, L, 2007)
"Our data suggest that the opioid system, particularly beta-endorphin, is involved in the perception of pain in duodenal ulcer disease, which explains the silent clinical characteristics of some peptic ulcers."3.69Beta-endorphin in silent duodenal ulcer. ( Chianelli, M; Delle Fave, G; Mariani, P; Negri, M; Tonnarini, GF, 1995)
"Randomized patients with available aspirin dosing information in COGENT (N = 3,752) were divided into "low-dose" (≤ 100 mg) and "high-dose" (>100 mg) aspirin groups."2.82Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. ( Bhatt, DL; Cannon, CP; Cohen, M; Cryer, BL; Doros, G; Goldsmith, MA; Hsieh, WH; Laine, L; Lanas, A; Lapuerta, P; Liu, Y; Schnitzer, TJ; Shook, TL; Vaduganathan, M, 2016)
"Lansoprazole or ranitidine was given to 133 patients for 4-8 weeks in a double-blind, randomized, parallel group, multicentre trial."2.69Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group. ( Jansen, JB; Van Oene, JC, 1999)
"Hypogonadism has been established as a cause of osteoporosis in males, and in this case would explain the occurrence of fractures in the absence of other major risk factors."1.31Osteoporosis with underlying connective tissue disease: an unusual case. ( De Silva, M; Prasad, R, 2002)

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19906 (16.67)18.7374
1990's13 (36.11)18.2507
2000's11 (30.56)29.6817
2010's2 (5.56)24.3611
2020's4 (11.11)2.80

Authors

AuthorsStudies
Yongwatana, K1
Harinwan, K1
Chirapongsathorn, S1
Opuchar, K1
Sanpajit, T1
Piyanirun, W1
Puttapitakpong, C1
Truong, TM1
Apfelbaum, JL1
Danahey, K1
Schierer, E1
Ludwig, J1
George, D1
House, L1
Karrison, T1
Shahul, S1
Anitescu, M1
Choksi, A1
Hartman, S1
Knoebel, RW1
van Wijk, XMR1
Yeo, KJ1
Meltzer, DO1
Ratain, MJ1
O'Donnell, PH1
Kongkam, P1
Khongkha, W1
Lopimpisuth, C1
Chumsri, C1
Kosarussawadee, P1
Phutrakool, P1
Khamsai, S1
Sawanyawisuth, K1
Sura, T1
Phisalprapa, P1
Buamahakul, T1
Siwamogsatham, S1
Angsusing, J1
Poonniam, P1
Wanaratna, K1
Teerachaisakul, M1
Pongpirul, K1
Korff, CP1
Williamson, BG1
Goswami, SK1
Inceoglu, B1
Yang, J1
Wan, D1
Kodani, SD1
da Silva, CA1
Morisseau, C1
Hammock, BD1
Vaduganathan, M1
Bhatt, DL1
Cryer, BL1
Liu, Y1
Hsieh, WH1
Doros, G1
Cohen, M1
Lanas, A1
Schnitzer, TJ1
Shook, TL1
Lapuerta, P1
Goldsmith, MA1
Laine, L1
Cannon, CP1
Prasad, R1
De Silva, M1
Labenz, J1
Blum, AL1
Bolten, WW1
Dragosics, B1
Rösch, W1
Stolte, M1
Koelz, HR1
Laheij, RJ1
Van Rossum, LG1
Jansen, JB2
Verheugt, FW1
Osipenko, MF1
Venzhina, IuIu1
Dohmen, W1
Fuchs, W1
Archimandritis, AJ1
Nikolopoulou, V1
Kouklakis, G1
Paraskevas, E1
Avgerinos, A1
Tsianos, E1
Triantafillidis, JK1
Ulualp, S1
Brodsky, L1
Jerome, L1
Tonnarini, GF1
Delle Fave, G1
Chianelli, M1
Mariani, P1
Negri, M1
Witzel, L1
Gütz, H1
Hüttemann, W1
Schepp, W1
Hosking, SW1
Ling, TK1
Chung, SC1
Yung, MY1
Cheng, AF1
Sung, JJ1
Li, AK1
Arber, N1
Avni, Y1
Eliakim, R1
Swissa, A1
Melzer, E1
Rachmilewitz, D1
Konikoff, F1
Misra, SC1
Dasarathy, S1
Sharma, MP1
Petite, JP1
Slama, JL1
Licht, H1
Lemerez, M1
Coste, T1
Andrieu, J1
Grimaud, JC1
Julien, H1
Dupuis, J1
Sallerin, V1
Ahmed, W1
Qureshi, H1
Zuberi, SJ1
Alam, SE1
Valenzuela, JE1
Kogut, DG1
McCullough, AJ1
Colón Pagán, JR1
Shah, U1
Whipple, J1
Gilde, LR1
Simon, TJ1
Dekkers, CP1
Beker, JA1
Thjodleifsson, B1
Gabryelewicz, A1
Bell, NE1
Humphries, TJ1
Jones, R1
Crouch, SL1
Van Oene, JC1
Ge, ZZ1
Zhang, DZ1
Xiao, SD1
Chen, Y1
Hu, YB1
Dupas, JL1
Houcke, P1
Samoyeau, R1
Tröger, U1
Stötzel, B1
Martens-Lobenhoffer, J1
Gollnick, H1
Meyer, FP1
Convens, C1
Verhelst, J1
Mahler, C1
Glise, H1
Martinson, J1
Solhaug, JH1
Carling, L1
Unge, P1
Engström, G1
Hallerbäck, B1
Lauritsen, K2
Andersen, BN1
Havelund, T1
Laursen, LS1
Hansen, J1
Eriksen, J1
Jørgensen, T1
Rask-Madsen, J2
Mulder, CJ1
Tijtgat, GN1
Cluysenaer, OJ1
Nicolai, JJ1
Meyer, WW1
Hazenberg, BP1
Vogten, AJ1
Gerrits, C1
Stuifbergen, WH1
Archambault, AP1
Pare, P1
Bailey, RJ1
Navert, H1
Williams, CN1
Freeman, HJ1
Baker, SJ1
Marcon, NE1
Hunt, RH1
Sutherland, L1
Rune, SJ1
Bytzer, P1
Kelbaek, H1
Jensen, KG1
Bendtsen, F1
Linde, J1
Højlund, M1
Andersen, HH1
Spiro, HM1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care[NCT03729180]1,900 participants (Anticipated)Interventional2019-01-22Recruiting
A Randomized, Double-Blind, Double-Dummy, Parallel Group, Phase 3 Efficacy and Safety Study of CGT-2168 Compared With Clopidogrel to Reduce Upper Gastrointestinal Events Including Bleeding and Symptomatic Ulcer Disease[NCT00557921]Phase 35,000 participants (Anticipated)Interventional2007-12-31Terminated (stopped due to Terminated by Sponsor)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

25 trials available for omeprazole and Ache

ArticleYear
Curcuma longa Linn versus omeprazole in treatment of functional dyspepsia: A randomized, double-blind, placebo-controlled trial.
    Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:2

    Topics: Curcuma; Curcumin; Double-Blind Method; Dyspepsia; Humans; Omeprazole; Pain; Quality of Life; Treatm

2022
Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial.
    Anesthesia and analgesia, 2022, 11-01, Volume: 135, Issue:5

    Topics: Female; Humans; Hydralazine; Male; Omeprazole; Oxycodone; Pain; Pantoprazole; Perioperative Care; Ph

2022
Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial.
    BMJ evidence-based medicine, 2023, 11-22, Volume: 28, Issue:6

    Topics: Adult; Curcumin; Dyspepsia; Female; Humans; Middle Aged; Omeprazole; Pain; Proton Pump Inhibitors

2023
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    Journal of the American College of Cardiology, 2016, Apr-12, Volume: 67, Issue:14

    Topics: Aged; Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspepsia;

2016
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Gut, 2002, Volume: 51, Issue:3

    Topics: Adult; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Dicl

2002
Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial.
    Alimentary pharmacology & therapeutics, 2003, Jul-01, Volume: 18, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents;

2003
Effects of rabeprazole on early symptom relief in gastro-oesophageal reflux disease: the Hellenic Rabeprazole Study Group surveillance study.
    Current medical research and opinion, 2005, Volume: 21, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Benzi

2005
Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
    Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Administration, Oral; Adult; Aged; Aged, 80

1995
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.
    Lancet (London, England), 1994, Feb-26, Volume: 343, Issue:8896

    Topics: Adult; Aged; Antacids; Biopsy; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer

1994
A multicenter, double-blind, randomized controlled study of omeprazole versus ranitidine in the treatment of duodenal ulcer in Israel.
    Israel journal of medical sciences, 1994, Volume: 30, Issue:10

    Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Isra

1994
Omeprazole versus famotidine in the healing and relapse of duodenal ulcer.
    Alimentary pharmacology & therapeutics, 1993, Volume: 7, Issue:4

    Topics: Absenteeism; Adult; Analgesics; Antacids; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; H

1993
[Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
    Gastroenterologie clinique et biologique, 1993, Volume: 17, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Double-Blin

1993
Omeprazole vs ranitidine in the healing of duodenal ulcer.
    JPMA. The Journal of the Pakistan Medical Association, 1993, Volume: 43, Issue:6

    Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle

1993
Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:12

    Topics: Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Omeprazole; Pain; Patient Co

1996
Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles;

1998
Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Double-Blind Me

1999
Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Endoscopy; Eructati

1999
Does eradication of Helicobacter pylori alone heal duodenal ulcers?
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Duodenal Ulcer; Female; Helicobac

2000
Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Meth

2001
Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research.
    Scandinavian journal of gastroenterology, 1991, Volume: 26, Issue:2

    Topics: Absenteeism; Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antacids; Drug Administrati

1991
Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer: double-blind comparative trial.
    Alimentary pharmacology & therapeutics, 1989, Volume: 3, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Duodenal Ulcer; Female; Humans; Mal

1989
Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. Danish Omeprazole Study Group.
    BMJ (Clinical research ed.), 1989, Mar-11, Volume: 298, Issue:6674

    Topics: Aged; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged;

1989
Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.d.) in duodenal ulcer healing and pain relief.
    Alimentary pharmacology & therapeutics, 1989, Volume: 3, Issue:5

    Topics: Adult; Aged; Antacids; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omepr

1989
Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief.
    Gastroenterology, 1988, Volume: 94, Issue:5 Pt 1

    Topics: Adult; Aged; Antacids; Cimetidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Admin

1988
Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial.
    The New England journal of medicine, 1985, Apr-11, Volume: 312, Issue:15

    Topics: Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Clinical Trials as Topic; Double-Blind M

1985

Other Studies

11 other studies available for omeprazole and Ache

ArticleYear
Clinical Presentation of Chiari-like Malformation in 2 Persian Cats.
    Topics in companion animal medicine, 2020, Volume: 41

    Topics: Aggression; Animals; Anxiety; Arnold-Chiari Malformation; Brain; Cat Diseases; Cats; Craniosynostose

2020
Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
    Toxicology and applied pharmacology, 2015, Dec-15, Volume: 289, Issue:3

    Topics: Analgesics; Animals; Cytochrome P-450 Enzyme System; Dinoprostone; Enzyme Inhibitors; Epoxide Hydrol

2015
Osteoporosis with underlying connective tissue disease: an unusual case.
    Annals of the New York Academy of Sciences, 2002, Volume: 966

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Accidental Falls; Adult; Anti-Ulcer Agents; Antibodies, Ant

2002
[Problems of excretory insufficiency of the pancreas].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2004, Issue:4

    Topics: Adolescent; Adult; Aged; Famotidine; Feces; Female; Histamine H2 Antagonists; Humans; Male; Middle A

2004
[Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
    MMW Fortschritte der Medizin, 2005, Mar-03, Volume: 147, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Esophagitis, Peptic; Humans; Lansoprazol

2005
Nasal pain disrupting sleep as a presenting symptom of extraesophageal acid reflux in children.
    International journal of pediatric otorhinolaryngology, 2005, Volume: 69, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Child, Preschool; Diet; Gastroesophageal

2005
Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia.
    Pain research & management, 2007,Autumn, Volume: 12, Issue:3

    Topics: Amitriptyline; Analgesics; Anti-Ulcer Agents; Anticoagulants; Antidepressive Agents; Anxiety; Cardio

2007
Beta-endorphin in silent duodenal ulcer.
    European journal of gastroenterology & hepatology, 1995, Volume: 7, Issue:4

    Topics: Adult; beta-Endorphin; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Nociceptors; Omeprazole; P

1995
Drug points: Severe myalgia from an interaction between treatments with pantoprazole and methotrexate.
    BMJ (Clinical research ed.), 2002, Jun-22, Volume: 324, Issue:7352

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Barrett Esophagus; Benzimidazoles; Dermatologic Agents; Dru

2002
Painful gynaecomastia during omeprazole therapy.
    Lancet (London, England), 1991, Nov-02, Volume: 338, Issue:8775

    Topics: Aged; Drug Administration Schedule; Esophagitis, Peptic; Gynecomastia; Humans; Male; Omeprazole; Pai

1991
Duodenal ulcer disease.
    Hospital practice (Office ed.), 1985, Aug-15, Volume: 20, Issue:8

    Topics: Anti-Ulcer Agents; Benzimidazoles; Campylobacter Infections; Cimetidine; Duodenal Ulcer; Duodenoscop

1985